Clinical evaluation of intravenous nicorandil (Sigmart®) in patients with acute heart failure - The multi-center, randomized double blind placebo-controlled phase III study

Japanese Pharmacology and Therapeutics

Volumn 36, Issue 1 SUPPL. 1, 2008, Pages

  Kato, Kazuzo ^a,b   Takano, Teruo ^c,d   Katagiri, Takashi ^e,f   Asanoi, Hidetsugu ^g,h   Nakashima, Mitsuyoshi ⁱ   Sakanashi, Matao ^j  

^a Cardiovascular Institute Hospital

^b Keiwa Clinic

^c NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^d Nippon Medical School Foundation

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f SHOWA UNIVERSITY   (Japan)

^g UNIVERSITY OF TOYAMA   (Japan)

^h Imizu City Hospital

ⁱ Hamamatsu Institute of Clinical Pharmacology and Therapeutics   (Japan)

^j UNIVERSITY OF THE RYUKYUS   (Japan)

more..

Author keywords

Acute heart failure; Cardiac index; Nicorandil; Pulmonary artery wedge pressure; Sigmart

Indexed keywords

NICORANDIL; PLACEBO;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART INDEX; HEART STROKE VOLUME; HUMAN; LABORATORY TEST; LUNG WEDGE PRESSURE; MALE; MULTICENTER STUDY; PATIENT CODING; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR RESISTANCE;

EID: 39149084979     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Japanese source
2. Uchida Y, Yoshimoto N, Murao S. Effect of 2-nicotinamidethyl nitrate (SG 75) on coronary circulation. Jpn Heart J 1978 ; 19 : 112-24.
3. Japanese source
4. Sakai K, Shiraki Y, Nabata H. Cardiovascular effects of a new coronary vasodilator N- (2-hydroxyethyl) nicotinamide nitrate (SG-75) : comparison with nitroglycerin and diltiazem. J Cardiovasc Pharmacol 1981 ; 3 : 139-50.
5. Kamijo T, Kamei K, Sugo I, Kamiyama T, Sudo H, Ohba Y. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure : a comparison with cromakalim and nitroglycerin. J Cardiovasc Pharmacol 1999 ; 33 : 93-101.
6. Kamijo T, Tomaru T, Miwa AY, Nakamura F, Kido H, Uchida Y. Hemodynamic effects of nicorandil on acute congestive heart failure in dogs. Asia Pacific J Pharmacol 1996 ; 11 : 141-8.
7. Sakai K, Kuromaru O. Nitrate tolerance : comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs. J Cardiovasc Pharmacol 1987 ; 10 (Suppl 8) : S17-24.
8. Tsutamoto T, Kinoshita M, Nakae I, Maeda Y, Wada A, Yabe T, et al. Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure. Am Heart J 1994 ; 127 : 866-73.
9. Larsen AI, Gøransson L, Aarsland T, Tamby JF, Dickstein K. Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure. Am Heart J 1997 ; 134 : 435-41.
10. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 1989 ; 63 : 18J-24J.
11. Holzman S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol 1983 ; 5 : 364-70.
12. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, et al. Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 1981 ; 218 : 248-59.
13. Japanese source
14. Japanese source
15. Japanese source
16. Japanese source
17. Japanese source
18. Yanagisawa T, Hashimoto H, Taira N. Interaction of potassium channel openers and blockers in canine atrial muscle. Br J Pharmacol 1989 ; 97 : 753-62.